Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 2/20 | 0.59 |
| ▸ | NOS2 | P35228 | 2/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.33 |
| ▸ | MBOAT4 | Q96T53 | 2/20 | 0.32 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.32 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.31 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6286190 | 0.84 | SLC6A4 (0.62) | SLC6A4NOS2CYP3A4AAK1MBOAT4 | |
| SCHEMBL6280985 | 0.76 | SLC6A4 (0.49) | SLC6A4NOS2CYP3A4AAK1MBOAT4 | |
| SCHEMBL2532315 | 0.75 | SLC6A4 (0.49) | SLC6A4NOS2CYP3A4AAK1GPR119 | |
| SCHEMBL6050236 | 0.74 | SLC6A4 (1.00) | SLC6A4NOS2CYP3A4AAK1GPR119 | |
| SCHEMBL6892410 | 0.74 | SLC6A4 (1.00) | SLC6A4NOS2CYP3A4AAK1GPR119 | |
| SCHEMBL6186136 | 0.73 | SLC6A4 (0.71) | SLC6A4NOS2CYP3A4AAK1GPR119 | |
| SCHEMBL6050141 | 0.73 | SLC6A4 (0.88) | SLC6A4NOS2CYP3A4AAK1GPR119 | |
| SCHEMBL6285580 | 0.71 | SLC6A4 (0.45) | SLC6A4NOS2CYP3A4AAK1MBOAT4 | |
| SCHEMBL2528648 | 0.71 | SLC6A4 (0.46) | SLC6A4NOS2MBOAT4GPR119TRPV1 | |
| SCHEMBL6050379 | 0.70 | SLC6A4 (0.76) | SLC6A4NOS2GPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1572655-A2 | NOVEL ARYLHETEROALKYLAMINE DERIVATIVES | AstraZeneca AB (SE) | 2005-09-14 | — | — | EP | claimed |
| WO-2002090332-A2 | NOVEL AEYLHETEROALKYLAMINΕ DERIVATIVES | ASTRAZENECA AB (SE) | 2002-11-14 | — | — | WO | claimed |
| EP-1572655-A2 | NOVEL ARYLHETEROALKYLAMINE DERIVATIVES | AstraZeneca AB (SE) | 2005-09-14 | — | — | EP | disclosed |
| WO-2002090332-A2 | NOVEL AEYLHETEROALKYLAMINΕ DERIVATIVES | ASTRAZENECA AB (SE) | 2002-11-14 | — | — | WO | disclosed |